Nutritional assessment and treatment of patients with liver cirrhosis

Nutrition

Volumn 29, Issue 11-12, 2013, Pages 1279-1285

  Moctezuma Velázquez, Carlos ^a   García Juárez, Ignacio ^a   Soto Solís, Rodrigo ^a   Hernández Cortés, Juan ^a   Torre, Aldo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Bioelectrical impedance; Body composition; Branched chain amino acid; Decompensated cirrhosis; Hand grip strength; Malnutrition

Indexed keywords

ADIPONECTIN; BRANCHED CHAIN AMINO ACID; CHOLECYSTOKININ; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTHROPOMETRIC PARAMETERS; ASCITES; BIOCHEMISTRY; BIOENERGY; CHRONIC LIVER DISEASE; DIET THERAPY; DIETARY COMPLIANCE; DIETARY FIBER; DISEASE COURSE; HAND GRIP; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MALNUTRITION; MUSCLE FUNCTION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CALORIE MALNUTRITION; PROTEIN FUNCTION; PROTEIN RESTRICTION; REVIEW;

BIOELECTRICAL IMPEDANCE; BODY COMPOSITION; BRANCHED CHAIN AMINO ACID; DECOMPENSATED CIRRHOSIS; HAND GRIP STRENGTH; MALNUTRITION;

ADIPONECTIN; ANTHROPOMETRY; BIOLOGICAL MARKERS; CYTOKINES; DIETARY CARBOHYDRATES; DIETARY PROTEINS; ELECTRIC IMPEDANCE; HAND STRENGTH; HUMANS; LEPTIN; LIVER CIRRHOSIS; MICRONUTRIENTS; MUSCLE, SKELETAL; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROTEIN-ENERGY MALNUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84884979778     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.03.017     Document Type: Review

References (88)

1. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
2. National Center for Health Statistics. Health, United States, 2005. With chartbook on trends in the health of Americans. Hyattsville, MD;2005.
3. Méndez-Sánchez N., Villa A.R., Chávez-Tapia N.C., Ponciano-Rodríguez G., Almeda-Valdés P., González D., et al. Trends in liver disease prevalence inMexico from 2005 to 2050 through mortality data. Ann Hepatol 2005, 4:52-55.
4. García-Tsao G., Lim J.K. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009, 104:1802-1829.
5. Instituto Nacional de Estadística y Geografía (INEGI), http://www.inegi.org.mx.
6. Cheung K., Lee S.S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012, 10:117-125.
7. Alvares-da-Silva M.R., Reberbel da S.T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005, 21:113-117.
8. Cabré E., Gassull M.A. Nutrition in liver disease. Curr Opin Clin Nutr Metab Care 2005, 8:545-551.
9. Norman K., Kirchner H., Lochs H., Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006, 12:3380-3385.
10. Kondrup J. Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 2006, 20:547-560.
11. Fukushima K., Ueno Y., Kawagishi N., Kondo Y., Inoue J., Kakazu E., et al. The nutritional index CONUT is useful for predicting long-term prognosis of patients with end-stage liver disease. Tohoku J Exp Med 2011, 224(3):215-219.
12. Tsiaousi E.T., Hatzitolios A.I., Trygonis S.K., Savopoulos C.G. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol 2008, 23:527-533.
13. Periyalwar P., Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012, 16:95-131.
14. Nutritional status in cirrhosis, Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. J Hepatol 1994, 21:317-325.
15. Englesbe M.J., Patel S.P., He K., Lynch R.J., Schaubel D.E., Harbaugh C., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010, 211:271-278.
16. Peng S., Plank L.D., McCall J.L., Gillanders L.K., McIlroy K., Gane E.J. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007, 85:1257-1266.
17. Carvalho L., Parise E.R. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006, 43:269-274.
18. Aqel B.A., Scolapio J.S., Dickson R.C., Burton D.D., Bouras E.P. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005, 3:1095-1100.
19. Johnson T.M., Overgard E.B., Cohen A.E., Dibaise J.K. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013, 28:15-29.
20. Campillo B., Richardet J.P., Scherman E., Bories P.N. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003, 19:515-521.
21. Rode A., Fourlanos S., Nicoll A. Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol Clin Biol 2010, 34:618-620.
22. Nelson J.K. Dietética y Nutrición. Manual de la Clínica Mayo 1996, Mosby/Doyma Libros, Madrid. 7th ed.
23. Tilg H., Wilmer A., Vogel W., Herold M., Nölchen B., Judmaier G., et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992, 103:264-274.
24. Shawcross D.L., Shabbir S.S., Taylor N.J., Hughes R.D. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010, 51:1062-1069.
25. Gunsar F., Riamondo M.L., Jones S., Terreni N., Wong C., Patch D., et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006, 24:563-572.
26. Marsha M.Y., Madden A.M., Soulsby C.T., Morris R.W. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006, 44:823-835.
27. Putadechakum S., Klangjareonchai T., Soponsaritsuk A., Roongpisuthipong C. Nutritional status assessment in cirrhotic patients after protein supplementation. ISRN Gastroenterol 2012, 2012:1-4.
28. Campillo B., Richardet J.P., Bories P.N. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol 2006, 30:1137-1143.
29. Campillo B. Assessment of Nutritional Status and Diagnosis of Malnutrition in Patients with Liver Disease. Nutrition, diet therapy, and the liver 2010, 33-36. Taylor & Francis Group CRC, Boca Raton. V.R. Preedy, R. Lakshman, S.R. Rajaskanthan, R.R. Watson (Eds.).
30. Guglielmi F.W., Mastronuzzi T., Pietrini L., Panarese A., Panella C., Francavilla A. The RXc graph in evaluating and monitoring fluid balance in patients with liver cirrhosis. Ann N Y Acad Sci 1999, 873:105-111.
31. Pirlich M., Schütz T., Spachos T., Erti S., Weiss M.L., Lochs H., et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000, 32:1208-1215.
32. Piccoli A., Nescolarde L.D., Rosell J. Análisis convencional y vectorial de bioimpedancia en la práctica clínica. Nefrología 2002, 22:228-238.
33. Espinosa-Cuevas M.L., Rivas-Rodriguez L., Gonzalez-Medina E.C., Atilano-Carsi X., Miranda-Alatriste P., Correa-Rotter R. Bioimpedance vector analysis for body composition in Mexican population. Rev Invest Clin 2007, 59:15-24.
34. Fernandes S.A., Bassani L., Nunes F.F., Aydos M.E., Alves A.V., Marroni C.A. Nutritional assessment in patients with cirrhosis. Arg Gastroenterol 2012, 49:19-27.
35. Horber F.F., Thomi F., Casez J.P., Fonteille J., Jaeger P. Impact of hyuddration status on body composition as measured by dual energy xray absortpiometry in normal avolunteers and patients on haemodialysis. Br J radiol 1992, 65:895-900.
36. Alberino F., Gatta A., Amodio P., Merkel C., DiPascoli L., Boffo G., et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001, 17:445-450.
37. Fuhrman P., Charney P., Mueller C.M. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004, 104:1258-1264.
38. Chang W.T., Ker C.G., Hung H.C., Lee K.T., Chen L.S., Chiang H.C., et al. Albumin and prealbumin may predict retinol status in patients with liver cirrhosis. Hepatogastroenterology 2008, 55:1681-1685.
39. Mezey E. Liver disease and nutrition. Gastroenterology 1978, 74:770-783.
40. Jonsson J.R., Moschen A.R., Hickman I.J., Richardson M.M., Kaser S., Clouston A.D., et al. Adiponectin and its receptors in patients with chronic hepatitis C. JHepatol 2005, 43:929-936.
41. Petit J.M., Minello A., Jooste V., Bour J.B., Galland F., Duvillard L., et al. Decreased plasma adiponectin concentrations are closely related to steatosis inhepatitis C virus-infected patients. J Clin Endocrinol Metab 2005, 90:2240-2243.
42. Tietge U.J., Boker K.H., Manns M.P., Bahr M.J. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004, 287:E82-E89.
43. Sohara N., Takagi H., Kakizaki S., Sato K., Mori M. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int 2004, 25:28-32.
44. Din X., Saxena N.K., Lin S., Xu A., Srinivasan S., Anania F.A. The role of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005, 166:1655-1699.
45. Beutler B., Cerami A. Cachectin. Tumor necrosis factor: a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988, 9:57-66.
46. Marra F., Bertolani C. Adipokines in liver diseases. Hepatology 2009, 50:957-969.
47. Huang Y.S., Hwang S.J., Chan C.Y., Wu J.C., Chao Y., Chang F.Y., et al. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi 1999, 62:327-333.
48. Wang Y.Y., Lo G.H., Lai K.H., Cheng J.S., Lin C.K., Hsu P.I. Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma. J Chin Med Assoc 2003, 66:593-598.
49. Shiraki M., Terakura Y., Iwasa J., Shimizu M., Miwa Y., Murakami N., et al. Elevated serum tumor necrosis factor-α and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis. Nutrition 2010, 26:269-275.
50. O'Donohue J., Williams R. Immunological control in primary biliary cirrhosis: the cytokine story. Clin Exp Immunol 1996, 105(2):199-201.
51. Tacke F., Wustefeld T., Horn R., Luedde T., Srinivas Rao A., Manns M.P., et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion invivo. J Hepatol 2005, 42:666-673.
52. Michitaka K., Hiraoka A., Kume M., Uehara T., Hidaka S., Ninomiya T., et al. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res 2010, 40:393-398.
53. Detsky A.S., McLaughlin J.R., Baker J.P., Johnston N., Whittaker S., Mendelson R.A., et al. What is subjective global assessment of nutritional status? 1987. Classical article. Nutr Hosp 2008, 23:400-407.
54. Tai M.L., Goh K.L., Mohd-Taib S.H., Rampal S., Mahadeva S. Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis. Nutr J 2010, 9:27.
55. Rantanen T., Harris T., Leveille S.G., Visser M., Foley D., Masaki K., et al. Muscle strength and body mass index as long term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000, 55:M168-M173.
56. Huisman E.J., Trip E.J., Siersema P.D., van Hoek B., van Erpekum K.J. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011, 23:982-989.
57. Montano-Loza A.J., Meza-Junco J., Prado C.M., Lieffers J.R., Baracos V.E., Bain V.G., et al. Muscle wasting is associated with mortality in patients with cirrrhosis. Clin Gastroenterol Hepatol 2012, 10:166-173.
58. Holt E.W., Frederick R.T., Verhille M.S. Prognostic value of muscle wasting in cirrhotic patients. Clin Gastroenterol Hepatol 2012, 10:156-157.
59. Merli M. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009, 24:211-221.
60. Plauth M., Cabré E., Riggio O., Assis-Camilo M., Pirlich M., Kondrup J., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
61. Castellanos-Fernández M. Nutrición y cirrosis hepática. Acta Médica 2003, 11:26-37.
62. Manguso F., D'Ambra G., Menchise A., Sollazzo R., D'Agostino L. Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study. Clin Nutr 2005, 24:751-759.
63. Cunha L., Happi-Nono M., Guibert A.L., Nidegger D., Beau P., Beauchant M. Effects of prolonged oral nutritional support in malnourished cirrhotic patients: Results of a pilot study. Gastroenterol Clin Biol 2004, 28:36-39.
64. Owen O.E., Reiche F.A., Mozzoli M.A., et al. Hepatic, gut and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Inves 1981, 68:240-252.
65. Owen O.E., Trapp V.E., Reichard G.A., Mozzoli M.A., Moctezuma J., Paul P., et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983, 72:1821-1832.
66. Moriwaki H., Shiraki M., Fukushima H., Shimizu M., Iwasa J., Naiki T., et al. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 2008, 38(Suppl 1):S102-S106.
67. Swart G.R., Zillikens M.C., van Vuure J.K., van den Berg J.W. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989, 299:1202-1203.
68. Yamanaka-Okumura H., Nakamura T., Miyake H., Takeuchi H., Katayama T., Morine Y., et al. Effect of long-term late-evening snack on health-related quality on life in cirrhotic patients. Hepatol Res 2010, 40:470-476.
69. Yamauchi M., Takeda K., Sakamoto K., Ohata M., Toda G. Effect of oral branched chain amino acid supplementation in the late evening on thenutritional state of patients with liver cirrhosis. Hepatol Res 2001, 21:199-204.
70. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010, 26:482-490.
71. Tischler M.E., Desautels M., Goldberg A.L. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?. J Biol Chem 1982, 257:1613-1621.
72. Kato M., Miwa Y., Tajika M., Hiraoka T., Muto Y., Moriwaki H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med 1998, 37:429-434.
73. Muto Y., Sato S., Watanabe A., Moriwaki H., Suzuki K., Kato A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
74. Muto Y., Sato S., Watanabe A., Moriwaki H., Suzuki K., Kato A., et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006, 35:204-214.
75. Nakaya Y., Okita K., Suzuky K., Moriwaki H., Kato A., Miwa Y., et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-120.
76. Suzuki K., Endo R., Kohgo Y., Ohtake TUeno Y., Kato A., et al. Guidelines on nutritional management in Japanese patients with liver cirrhosis from theperspective of preventing hepatocellular carcinoma. Hepatology Res 2012, 42:621-626.
77. Kato A., Suzuki K. How to select BCAA preparations. Hepatol Res 2004, 30S:30-35.
78. Koretz R.L., Avenell A., Lipman T.O. Nutritional support for liver disease. Cochrane Database Syst Rev 2012, 5:CD008344.
79. Matos C., Porayko M.K., Francisco-Ziller N., DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol 2002, 35:391-397.
80. Pappa H.M., Bern E., Kamin D., Grand R.J. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol 2008, 24:176-183.
81. Bianchi G. Nutritional effects of oral zinc supplementation in cirrhosis. Nutr Res 2000, 20:1079-1089.
82. Olivera M., Villalobos J., Valdovinos M. Cirrosis. Principios de Gastroenterología 2000, 585-592. Méndez Editores, México DF. J. Villalobos, M. Valdovinos (Eds.).
83. Uribe M., de Regil L.M. Alimentación y nutrición en las enfermedades hepáticas. Nutriología médica 2008, 457-472. Médica Panamericana-Fundación Mexicana para la Salud, México DF. E. Casa-nueva, M. Kaufer-Horwitz, A.B. Pérez-Lizaur, P. Arroyo (Eds.).
84. Wahren J., Denis J., Desurmont P., Eriksson L.S., Escoffier J.M., Gauthier A.P., et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 1983, 3:475-480.
85. Dam G., Ott P., Aagaard N.K., Vilstrup H. Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 2013, E-pub ahead of print.
86. Cordoba J., López-Hellín J., Planas M., Sabín P., Sanpedro F., Castro F., et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004, 41:38-43.
87. Merli M., Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009, 24:211-221.
88. Cm Mueller The Amiercan Society for Parenterl and Enteral Nutrition Adult Nutrition Support Core Curriculum 2012, American Society for Parenteral and Enteral Nutrition, Silver Spring, MD. 2nd ed.